Literature DB >> 19520824

Abdelkefi A, Ladeb S, Torjman L, Ben Othman T, Lakhal A, Ben Romdhane N, El Omri H, Elloumi M, Belaaj H, Jeddi R, Aissaouï L, Ksouri H, Ben Hassen A, Msadek F, Saad A, Hsaïri M, Boukef K, Amouri A, Louzir H, Dellagi K, Ben Abdeladhim A, on behalf of the Tunisian Multiple Myeloma Study Group. Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trial. Blood. 2008;111:1805-1810.

Abderrahman Abdelkefi, Saloua Ladeb, Lamia Torjman, Tarek Ben Othman, Amel Lakhal, Neila Ben Romdhane, Moez Elloumi, Ramzi Jeddi, Lamia Aissaouï, Assia Ben Hassen, Fahmi Msadek, Ali Saad, Mohamed Hsaïri.   

Abstract

Entities:  

Year:  2009        PMID: 19520824     DOI: 10.1182/blood-2009-05-222927

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  Reiterative survival analyses of total therapy 2 for multiple myeloma elucidate follow-up time dependency of prognostic variables and treatment arms.

Authors:  Bart Barlogie; Elias Anaissie; Frits van Rhee; John D Shaughnessy; Jackie Szymonifka; Antje Hoering; Nathan Petty; John Crowley
Journal:  J Clin Oncol       Date:  2010-05-17       Impact factor: 44.544

2.  Thalidomide treatment for patients with previously untreated multiple myeloma: a meta-analysis of randomized controlled trials.

Authors:  Minjie Gao; Yuanyuan Kong; Houcai Wang; Bingqian Xie; Guang Yang; Lu Gao; Yiwen Zhang; Fenghuang Zhan; Bojie Dai; Yi Tao; Jumei Shi
Journal:  Tumour Biol       Date:  2016-02-23

3.  Phase I trial of bortezomib during maintenance phase after high dose melphalan and autologous stem cell transplantation in patients with multiple myeloma.

Authors:  Muneer H Abidi; Zartash Gul; Judith Abrams; Lois Ayash; Abhinav Deol; Marie Ventimiglia; Lawrence Lum; Stephanie Mellon-Reppen; Zaid Al-Kadhimi; Voravit Ratanatharathorn; Jeffrey Zonder; Joseph Uberti
Journal:  J Chemother       Date:  2012-06       Impact factor: 1.714

4.  Long-term follow-up of autotransplantation trials for multiple myeloma: update of protocols conducted by the intergroupe francophone du myelome, southwest oncology group, and university of arkansas for medical sciences.

Authors:  Bart Barlogie; Michel Attal; John Crowley; Frits van Rhee; Jackie Szymonifka; Philippe Moreau; Brian G M Durie; Jean-Luc Harousseau
Journal:  J Clin Oncol       Date:  2010-01-19       Impact factor: 44.544

5.  Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2012.

Authors:  Vânia Tietsche de Moraes Hungria; Edvan de Queiroz Crusoe; Adriana Alvarez Quero; Manuella Sampaio; Angelo Maiolino; Wanderley Marques Bernardo
Journal:  Rev Bras Hematol Hemoter       Date:  2013
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.